Immune response against medullary thyroid carcinoma (MTC) induced by parental and/or interleukin-2-secreting MTC cells in a rat model of human familial medullary thyroid carcinoma

Cancer Immunology Immunotherapy

Volumn 43, Issue 2, 1996, Pages 116-123

  Lausson, S ^a   Fournes, B ^a   Borrel, C ^a   Milhaud, G ^b   Treilhou Lahille, F ^a  

^a Centre d'Orsay   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

immunotherapy; interleukin 2; medullary thyroid carcinoma; rat

Indexed keywords

CANCER VACCINE; CD8 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; EOSINOPHIL; GENETIC TRANSFECTION; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; THYROID MEDULLARY CARCINOMA;

ANIMALS; CARCINOMA, MEDULLARY; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DISEASE MODELS, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-2; KILLER CELLS, NATURAL; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED STRAINS; THYROID NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029845608     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050311     Document Type: Article

References (43)

1. Baker PE, Gillis S, Smith KA (1979) Monoclonal cytolytic T-cell lines. J Exp Med 149: 273
2. Boorman GA, DeLellis RE (1983) C cell hyperplasia. In: Jones TC (ed) Adenoma, carcinoma, thyroid, rat, endocrine system. Springer, Berlin Heidelberg New-York
3. Bosco M, Giovarelli M, Forni M, Modesti A, Scarpa S, Masuelli L, Forni G (1990) Low doses of IL-4 injected perilymphatically in tumour-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol 145: 3136
4. Bouizar Z, Minvielle S, Treilhou-Lahille F, Rostène WH, Pidoux E, Feingold N, Milhaud G, Moukhtar MS (1989) Loss of calcitonin receptors: a genetically transmitted defect in rats with high incidence of C cell tumors. Cancer Res 49: 5199
5. Brideau RJ, Carter PB, McMaster WR, Mason DW, Williams AF (1980) Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol 10: 609
6. Bubenik J, Simova J, Jandlova T (1990) Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2cDNA and constitutively producing IL-2. Immunol Lett 23: 287
7. Cantrell DA, Robins RA, Brooks CG, Baldwin RW (1982) Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte sub-sets. Immunology 45: 97
8. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic IL-2 gene. J Immunol 149: 3627
9. Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E (1993) Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells. J Exp Med 177: 1127
10. Dallman MJ, Mason DW, Webb M (1982) The roles of host and donor cells in the rejection of skin allografts by T cell-deprived rats injected with syngeneic T cells. Eur J Immunol 12: 511
11. Delehaye MC, Bouizar Z, Pidoux E, Segond N, Treilhou-Lahille F, Milhaud G, Moukhtar MS (1990) Genetic origin of increased calcitonin mRNA levels in rats with high incidence of C cell tumours. Biochem Biophys Res Commun 167: 232
12. Delisle MJ (1988) Cirveillance au long cours des cancers médullaires de la thyroide. Ann Endocrinol 49: 51
13. Fearon EF, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397
14. Festing MF (1979) Inbred Strains. In: Baker, Russel, Weithbross (eds) The laboratory rat, vol 1. Biology and diseases. Academic Press, New York
15. Festing MF, Staats J (1973) Standardized nomenclature for inbred strains of rats. Transplantation 16: 221
16. Gansbacher B, Zier KBD, Cronin K, Bannerji R, Gilboa E (1990) Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172: 1217
17. Gilboa E, Lyerly HK, Vieweg J, Saito S (1994) Immunotherapy of cancer using cytokine gene-modified tumor vaccines. Semin Cancer Biol 5: 409
18. Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon G. Proc Nat Acad Sci USA 90: 2774
19. Hoefnagel CA, Delprat CC, Zanin D, School JB van der (1988) New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med 13: 159
20. Hünig T, Wallny HJ, Hartley JK, Lawetzky A, Tiefenthaler G (1989) A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. J Exp Med 169: 73
21. Iwanuma Y, Kato K, Yagita H, Okumura K (1995) Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene. Cancer Immunol Immunother 40: 17
22. Karasuyama H, Melchers F (1988) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 18: 97
23. + IL-2 natural killer cells. Nature 358: 66
24. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319: 675
25. Khattab M, Pidoux E, Volle GE, Bouizar Z, Calmettes C, Milhaud G, Moukhtar MS, Treilhou-Lahille F (1989) Early calcitonin hypersecretion and C cell hyperplasia in rats with high incidence of C cell tumor. Bone Miner 6: 249
26. +) lymphocytes in IL-2-stimulated NK cell proliferation. Scand Immunol 41: 70
27. Lausson S, Volle GE, Bourges M, Pidoux E, Borrel C, Milhaud G, Moukhtar MS, Jullienne A, Treilhou-Lahille F (1995) Calcitonin secretion, C cell differentiation and proliferation, during the spontaneous development of murine medullary carcinoma (MTC). Virchows Arch A 426: 611
28. Ley V, Roth C, Langlade-Demoyen P, Larsson-Sciard EL, Kourilsky P (1990) A novel approach for the induction of specific cytolytic T cells in vivo. Res Immunol 141: 855
29. Ley V, Langlade-Demoyen P, Kourilsky P, Larsson-Sciard EL (1991) Interleukin-2 dependent activation of tumor specific T lymphocytes in vivo. Eu J Immunol 21: 581
30. Lovik G, Vaage JT, Naper C, Benestad HB, Rolstad B (1995) Recruitment of alloreactive natural killer cells to the rat peritoneum by a transfected cell line secreting rat recombinant interleukin-2. J Immunol Methods 179: 59
31. Melvin KEW, Tashjian AH Jr, Miller HH (1972) Studies in familial (medullary) thyroid carcinoma. Recent Progress Hormone Res 28: 399
32. Mir LM, Roth C, Orlowski S, Quintincolonna F, Fradelizi D, Belehradek J, Kourilsky P (1995) Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother 17: 30
33. Nong Y, Titus RG, Ribeiri JMC, Remold HG (1989) Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 143: 45
34. Roth C, Mir LM, Cressent M, Quitin-colonna F, Ley V, Fradelizi D, Kourilsky P (1992) Inhibiton of tumor growth by histoincompatible cells expressing interleukin-2. Int Immunol 4: 1429
35. Roth C, Kourilsky P, Ojcius DM (1994) Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule. Eur J Imrnunol 24: 2110
36. Roth C, Rochiitz C, Kourilsky P (1994) Immune response against tumors. Adv Immunol 281
37. Ruppert JM, Eggleston JC, deBustros A, Baylin SB (1986) Disseminated calcitonin-poor medullary carcinoma in a patient with calcitonin-rich primary tumor. Am J Surg Pathol 10: 513
38. Saad MF, Guido JJ, Samaan NA (1983) Treatment of medullary carcinoma of the thyroid. J Clin Endocrinol Metab 57: 124
39. Siegel JP, Sharon M, Smith PL, Leonard WJ (1987) The 1L-2 receptor beta chain (p70): role in mediating signals tor LAK, NK, and proliferative activities. Science 238: 75
40. Tepper RI, Coffman RL, Leder P (1992) An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257: 548
41. Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 47: 187
42. Vieweg J, Rosenthal F, Bannerji R, Heston WDW, Fair WR, Gansbacher B, Gilboa E (1994) Immunotherapy of prostate cancer in the dunning rat model: use of cytokine gene modified tumor vaccines. Cancer Res 54: 1760
43. Zeitinoglu FS, DeLellis RE, Gagel RF, Wolfe HJ, Tashjian AH (1980) Establishment of a calcitonin-producing rat medullary thyroid carcinoma cell line. I. Morphological studies of the tumor and cells in culture. Endocrinology 107: 509